Priming of rotational behavior by a dopamine receptor agonist in hemiparkinsonian rats: Movement-dependent induction

Neuroscience

Volumn 158, Issue 4, 2009, Pages 1625-1631

  Simola, N ^a   Di Chiara, G ^a,b   Daniels, W M U ^c   Schallert, T ^d   Morelli, M ^a,b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

^c University of KwaZulu Natal Faculty of Health Sciences   (South Africa)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

6 OHDA; dopamine receptor; motor information processing; neuroplasticity; striatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; APOMORPHINE; METYRAPONE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; DENERVATION; IMMOBILIZATION; MALE; MOTOR PERFORMANCE; NEUROCHEMISTRY; NONHUMAN; OUTCOME ASSESSMENT; PARKINSONISM; PRIORITY JOURNAL; RAT; STIMULATION; STRESS;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGONISTS; ENZYME INHIBITORS; FUNCTIONAL LATERALITY; MALE; METYRAPONE; MOVEMENT; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; ROTAROD PERFORMANCE TEST; ROTATION; TIME FACTORS;

EID: 60349104669     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.11.009     Document Type: Article

References (51)

1. Badiani A., Browman K.E., and Robinson T.E. Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine. Brain Res 674 (1995) 291-298
2. Calabresi P., Centonze D., Gubellini P., Marfia G.A., and Bernardi G. Glutamate-triggered events inducing corticostriatal long-term depression. J Neurosci 19 (1999) 6102-6110
3. Calabresi P., Picconi B., Tozzi A., and Di Filippo M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 30 (2007) 211-219
4. Calon F., Hadj Tahar A., Blanchet P.J., Morissette M., Grondin R., Goulet M., Doucet J.P., Robertson G.S., Nestler E., Di Paolo T., and Bédard P.J. Dopamine-receptor stimulation: biobehavioral and biochemical consequences. Trends Neurosci 23 10 suppl (2000) S92-S100
5. Calvo N., Martijena I.D., Molina V.A., and Volosin M. Metyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress. Brain Res 800 (1998) 227-235
6. Calvo N., and Volosin M. Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint. Neuroendocrinology 73 (2001) 261-271
7. Carta A.R., Fenu S., Pala P., Tronci E., and Morelli M. Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats. Eur J Neurosci 18 (2003) 2563-2572
8. Chase T.N., and Oh J.D. Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism. Trends Neurosci 23 10 Suppl (2000) S86-S91
9. Consolo S., Morelli M., Rimoldi M., Giorgi S., and Di Chiara G. Increased striatal expression of glutamate decarboxylase 67 after priming of 6-hydroxydopamine-lesioned rats. Neuroscience 89 (1999) 1183-1187
10. Dal-Zotto S., Martí O., and Armario A. Glucocorticoids are involved in the long-term effects of a single immobilization stress on the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 28 (2003) 992-1009
11. Di Chiara G., Morelli M., Barone P., and Pontieri F. Priming as a model of behavioural sensitization. Dev Pharmacol Ther 18 (1992) 223-227
12. Doyon J. Motor sequence learning and movement disorders. Curr Opin Neurol 21 (2008) 478-483
13. Gerdeman G.L., Partridge J.G., Lupica C.R., and Lovinger D.M. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 26 (2003) 184-192
14. 1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease. Neuroscientist 9 (2003) 455-462
15. Graybiel A.M. The basal ganglia: learning new tricks and loving it. Curr Opin Neurobiol 15 (2005) 638-644
16. Jenner P. Pharmacology of dopamine agonists in the treatment of Parkinson's disease. Neurology 58 4 Suppl 1 (2002) S1-S8
17. Jenner P. Molecular mechanisms of L-DOPA-induced dyskinesia. Nat Rev Neurosci 9 (2008) 665-677
18. Kelley A.E., Andrzejewski M.E., Baldwin A.E., Hernandez P.J., and Pratt W.E. Glutamate-mediated plasticity in corticostriatal networks: role in adaptive motor learning. Ann N Y Acad Sci 1003 (2003) 159-168
19. Klemcke H.G., Vallet J.L., and Christenson R.K. Lack of effect of metyrapone and exogenous cortisol on early porcine conceptus development. Exp Physiol 91 (2006) 521-530
20. Konitsiotis S., and Tsironis C. Levodopa-induced dyskinesia and rotational behavior in hemiparkinsonian rats: independent features or components of the same phenomenon?. Behav Brain Res 170 (2006) 337-341
21. Lane E.L., Cheetham S.C., and Jenner P. Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?. Exp Neurol 197 (2006) 284-290
22. Marin C., Rodriguez-Oroz M.C., and Obeso J.A. Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time?. Exp Neurol 197 (2006) 269-274
23. Martijena I.D., Calvo N., Volosin M., and Molina V.A. Prior exposure to a brief restraint session facilitates the occurrence of fear in response to a conflict situation: behavioral and neurochemical correlates. Brain Res 752 (1997) 136-142
24. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 50 (1996) 381-425
25. Morelli M., and Di Chiara G. Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning. Eur J Pharmacol 141 (1987) 101-107
26. Morelli M., and Di Chiara G. Stereospecific blockade of N-methyl-D-aspartate transmission by MK 801 prevents priming of SKF 38393-induced turning. Psychopharmacology 101 (1990) 287-288
27. Morelli M., Fenu S., Garau L., and Di Chiara G. Time and dose dependence of the "priming" of the expression of dopamine receptor supersensitivity. Eur J Pharmacol 162 (1989) 329-335
28. Morelli M., Fenu S., Pinna A., Cozzolino A., Carta A., and Di Chiara G. "Priming" to dopamine agonist-induced contralateral turning as a model of non-associative sensitization to the expression of the post-synaptic dopamine message. Behav Pharmacol 4 (1993) 389-397
29. Muslimovic D., Post B., Speelman J.D., and Schmand B. Motor procedural learning in Parkinson's disease. Brain 130 (2007) 2887-2897
30. Packard M.G., and Knowlton B.J. Learning and memory functions of the basal ganglia. Annu Rev Neurosci 25 (2002) 563-593
31. Pellegrino L.J., Pellegrino A.S., and Cushman A.J. A stereotaxic atlas of the rat brain (1979), Plenum Press, New York
32. Picconi B., Centonze D., Håkansson K., Bernardi G., Greengard P., Fisone G., Cenci M.A., and Calabresi P. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 6 (2003) 501-506
33. Picconi B., Pisani A., Barone I., Bonsi P., Centonze D., Bernardi G., and Calabresi P. Pathological synaptic plasticity in the striatum: implications for Parkinson's disease. Neurotoxicology 26 (2005) 779-783
34. Pinna A., Pontis S., and Morelli M. Expression of dyskinetic movements and turning behaviour in subchronic L-DOPA 6-hydroxydopamine-treated rats is influenced by the testing environment. Behav Brain Res 171 (2006) 175-178
35. Pisani A., Centonze D., Bernardi G., and Calabresi P. Striatal synaptic plasticity: implications for motor learning and Parkinson's disease. Mov Disord 20 (2005) 395-402
36. Pollack A.E., and Haisley E.C. NMDA glutamate receptor stimulation is required for the expression of D2 dopamine mediated responses in apomorphine primed 6-hydroxydopamine lesioned rats. Brain Res 897 (2001) 213-216
37. Pollack A.E., Turgeon S.M., and Fink J.S. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats. Neuroscience 79 (1997) 79-93
38. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39 (2000) 777-787
39. Schouenborg J. Learning in sensorimotor circuits. Curr Opin Neurobiol 14 (2004) 693-697
40. Senba E., and Ueyama T. Stress-induced expression of immediate early genes in the brain and peripheral organs of the rat. Neurosci Res 29 (1997) 183-207
41. Simola N., Morelli M., and Carta A.R. The 6-hydroxydopamine model of Parkinson's disease. Neurotox Res 11 (2007) 151-167
42. Smith A.D., and Zigmond M.J. Can the brain be protected through exercise?. Lessons from an animal model of parkinsonism. Exp Neurol 184 (2003) 31-39
43. Sonino N. Inhibition of adrenal steroid biosynthesis by metyrapone. In: Agarwal M.K. (Ed). Hormone antagonists (1982), Walter de Gruyter & Co, Berlin 419-429
44. Tang C., Pawlak A.P., Prokopenko V., and West M.O. Changes in activity of the striatum during formation of a motor habit. Eur J Neurosci 25 (2007) 1212-1227
45. Tillerson J.L., Cohen A.D., Philhower J., Miller G.W., Zigmond M.J., and Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci 21 (2001) 4427-4435
46. Vallone D., Pellecchia M.T., Morelli M., Verde P., Di Chiara G., and Barone P. Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. Mol Brain Res 52 (1997) 307-317
47. 1-receptor agonist. Mol Brain Res 61 (1998) 219-223
48. 1-receptor mediated turning behavior in 6-hydroxydopamine-lesioned rats. Neurosci Lett 290 (2000) 37-40
49. 1 dopamine receptors in the striatum. Neuroscience 153 (2008) 249-258
50. Wright R.L., Lightner E.N., Harman J.S., Meijer O.C., and Conrad C.D. Attenuating corticosterone levels on the day of memory assessment prevents chronic stress-induced impairments in spatial memory. Eur J Neurosci 24 (2006) 595-605
51. Zesiewicz T.A., Sullivan K.L., and Hauser R.A. Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment. Curr Neurol Neurosci Rep 7 (2007) 302-310